Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
LNP Trafficking Shapes Tissue-Specific T Cell Immunity
2026-10-06
The reference study shows that lipid nanoparticle composition can influence whether intramuscularly administered mRNA remains near the injection site or reaches organs such as the liver and lungs. This trafficking pattern was associated with tissue-specific antigen expression, resident cytotoxic T cell responses, and improved control of liver tumors in mice, providing a framework for designing vaccines around localized rather than exclusively systemic immunity.
-
Nebivolol Hydrochloride: Reading Evidence Across Pathways
2026-10-06
Nebivolol hydrochloride is a selective β1-adrenoceptor antagonist whose value extends beyond receptor pharmacology. This article examines what a sensitive yeast mTOR screen can—and cannot—conclude about nebivolol, creating a rigorous framework for interpreting negative pathway evidence in cardiovascular research.
-
Caspase-4 Activity and the Next Wave of Pyroptosis
2026-10-05
ER-targeted enzyme-instructed peptide assembly offers a compelling model of selective cancer-cell stress, but its relationship to inflammatory cell death remains unresolved. Caspase-4 activity measurement can help translational researchers distinguish ER stress, pyroptosis, apoptosis, and necroptosis without overinterpreting a single endpoint.
-
MOG (35-55) in Autoimmune Encephalomyelitis
2026-10-05
A source-grounded overview of MOG (35-55), its role in experimental autoimmune encephalomyelitis research, and the 2025 evidence linking PARP7, STAT1/STAT2, type I interferon signaling, and disease outcomes. The article separates supplier-reported product context from peer-reviewed findings and outlines translational limitations without providing experimental procedures.
-
α-Linolenic Acid: Reading Lipid Evidence
2026-10-04
α-Linolenic Acid (ALA) is a versatile omega-3 substrate for studying lipid fate, signaling, and disease biology. This evidence-focused guide distinguishes ALA mechanisms from arachidonic acid findings and defines where the current research supports interpretation versus where it remains hypothesis-generating.
-
Vidarabine Monohydrate: Evidence and Limits
2026-10-03
A source-grounded overview of Vidarabine monohydrate, covering its proposed antiviral principle, evidence quality, interpretation, research scope and key limitations.
-
LLY-507: Reading SMYD2 Biology in Context
2026-10-02
LLY-507 is a selective SMYD2 inhibitor for connecting methyltransferase target engagement with cancer and fibrosis phenotypes. This guide emphasizes compartment-aware interpretation, orthogonal assays, and the evidence boundaries surrounding preclinical SMYD2 research.
-
Triiodothyronine in Oligodendrocyte Assays
2026-10-01
Triiodothyronine (T3) can serve as a controlled endocrine variable when studying oligodendrocyte state and base-editing performance. This article connects T3 handling with the spatially concentrated ABE strategy for PLP1 correction while clearly separating established evidence from testable assay hypotheses.
-
Berberine Hydrochloride in Metabolic–AKI Research
2026-10-01
Berberine hydrochloride offers a mechanistically rich entry point for connecting AMPK-centered metabolic biology with inflammatory and cell-death programs relevant to acute kidney injury. This translational framework uses the A20–NEK7–NLRP3 findings reported in 2025 to define testable hypotheses while clearly separating established evidence from exploratory application.
-
Kupffer Cell Plasticity in Liver Metastasis
2026-09-30
Huang and colleagues show that liver metastasis-associated macrophages are maintained not only by recruited monocytes but also by local macrophage proliferation and infiltration of phenotypically reprogrammed Kupffer cells. Their lineage-tracing, proliferation-recording, flow-cytometry, imaging, and CITE-seq analyses explain why blocking monocyte-derived macrophages alone may have limited effects and inform more comprehensive experimental strategies.
-
NIH/3T3 Cells: Practical Culture and QC Guide
2026-09-30
This guide provides a practical recovery, expansion, and quality-control workflow for NIH/3T3 Cells (BC1017), supplied as a cryopreserved adherent mouse fibroblast population. The product is intended for controlled research workflows such as cell transfection studies, viral proliferation research, and oncogene research, but it is not a clinically validated, diagnostic, or quantitatively validated assay system.
-
Lapatinib (GW572016) Research Workflows
2026-09-29
Lapatinib (GW572016) enables receptor-aware studies spanning EGFR and HER2 kinase inhibition, cell proliferation, invasion, and angiogenesis-related phenotypes. This workflow emphasizes practical assay design and target-engagement controls so results from receptor-positive and receptor-negative models are interpreted correctly.
-
Direct Mouse Genotyping Kit Plus: SCA3 Workflow
2026-09-29
Build a faster, cleaner genotype-to-phenotype workflow for SCA3 mouse studies using direct tissue lysates and high-fidelity PCR. The approach supports transgene detection, colony screening, and pre-study cohort confirmation while preserving practical controls for inhibitor carryover and ambiguous bands.
-
QX77: Practical CMA Research Workflows
2026-09-28
QX77 is a molecular chaperone activator for probing LAMP2A- and Rab11-linked chaperone-mediated autophagy, with additional utility in embryonic stem cell differentiation studies. This guide translates its mechanism into dose-finding, flux-aware assays, and troubleshooting strategies while separating established product information from hypothesis-driven applications.
-
Dietary Arachidonic Acid and Vaccine Immunity
2026-09-28
A recent study reports that dietary arachidonic acid (ARA) strengthens rabies vaccine-induced neutralizing antibody responses in mice and accelerates their appearance in human volunteers. Its mechanistic findings connect ARA metabolism in lymph nodes with prostaglandin I2 signaling and B-cell functions, while leaving important questions about dosing, generalizability, and application to other fatty acids unresolved.